Gateway to China: AI Forum
On May 3rd 2019, BGTA and Cambridge Innovation Academy, together with Shanghai Morrow AI Tech Co, held the AI Forum “Gateway to China: the Future of Innovation in Artificial Intelligence”, attracting over 150 delegates that range from startups, research institutions, investment organisation, accelerator and government officials. Daniel Zeichner MP and Cllr Lewis Herbert delivered the closing remarks to encourage more collaboration between Shanghai and Cambridge in the AI sector.
The keynote speech was given by Lu Sen, Deputy Director Shanghai Development Research Center of Economy and Informatization and panel discussions were held with speakers including: Delta2020 Managing Partner Simon Thorpe; BGTA CEO Helen Wang; Shanghai Morrow Partner Gao Feng; University of Cambridge Professor Chris Lowe and Innovation Forum Founder Dr Marek Tyl.
Cambridge is fast becoming a key world centre for disruptive and world-changing science and technology in AI, Machine Learning and Robotics. The already vibrant and fast growing Cambridge Technology Cluster and the environment of Open Innovation in Cambridge combined with the availability of investment capital for technology companies ready to scale, together with the ever growing presence of Chinese technology and investments in the Cluster make it ideal for cross-continental collaboration.
In the Keynote Speech of Mr Lu Sen, Deputy Director Shanghai Development Research Center of Economy and Informatization, shared Shanghai’s vision, mission, and current development status, saying “Shanghai endeavours to build a leading international City by 2040. To realize this vision, we are keen on seeking new governance models and development momentum, and take the development of artificial intelligence as the main drive to build a world-class smart city.”
Two AI companies, Chief.AI and AlgoDynamix were selected to present at the Forum.
Chief.AI
Chief is a drug re-purposing company developing AI search engines consuming drug data from research papers, patents, clinical trials and patient records. Off-pathway effects of drugs are correlated and verified as potential novel, IP protectable drugs. This method produces drugs that can be fast-tracked into human trials faster and at a lower cost.
AlgoDynamix
AlgoDynamix is a pioneering portfolio risk analytics company focusing on financially disruptive events. Our customers include investment banks and asset managers including hedge funds, CTAs, and family offices. The deep data algorithms underpinning the AlgoDynamix analytics engine use primary data sources (the world’s global financial exchanges) and proprietary unsupervised machine learning technology.
About BGTA
BGTA is a Chinese corporate-backed accelerator that is committed to fostering the development of a global tech and investment ecosystem through accelerating tech companies from the UK, the EU and the US in China. Headquartered in London, with China-based operations, BGTA’s open innovation network includes world-class investors, technology companies, academic organisations and government institutions.
Companies accepted to the accelerators receive a six-month acceleration programme which includes office space, one to one mentoring, networking and technical support in setting up the business from I.T. infrastructure to recruiting local talent. The selected businesses will also get access to BGTA’s corporate partners’ networks of investors, government agencies and customers.
For further information visit https://www.bgta.co.uk/
